LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 44 filers reported holding LYRA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $241,000 | -22.5% | 60,000 | -15.9% | 0.00% | 0.0% |
| Q4 2021 | $311,000 | +6.5% | 71,313 | +122.8% | 0.00% | 0.0% |
| Q3 2021 | $292,000 | +52.9% | 32,014 | +34.5% | 0.00% | +50.0% |
| Q2 2021 | $191,000 | -30.8% | 23,800 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $276,000 | +1.8% | 23,800 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $271,000 | +1.9% | 23,800 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $266,000 | -1.5% | 23,800 | 0.0% | 0.00% | -40.0% |
| Q2 2020 | $270,000 | – | 23,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 2,780,261 | $11,426,873 | 2.01% |
| Nantahala Capital Management | 3,957,542 | $16,265,497 | 1.57% |
| Perceptive Advisors | 12,757,562 | $52,433,579 | 1.52% |
| PURA VIDA INVESTMENTS, LLC | 1,413,242 | $5,717,732 | 0.76% |
| Ikarian Capital, LLC | 978,626 | $4,022,153 | 0.64% |
| VR Adviser, LLC | 924,170 | $3,798,339 | 0.61% |
| Parkman Healthcare Partners LLC | 600,000 | $2,466,000 | 0.43% |
| DAFNA Capital Management LLC | 361,084 | $1,484,055 | 0.41% |
| Soleus Capital Management, L.P. | 592,417 | $2,434,834 | 0.27% |
| ARMISTICE CAPITAL, LLC | 4,012,036 | $16,489,468 | 0.24% |